Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience

Annals of Oncology : Official Journal of the European Society for Medical Oncology
A K GantiJ O Armitage

Abstract

The aim of the study was to determine the outcome and clinical features predictive of survival in patients with follicular lymphoma (FL) treated aggressively and to determine the rate of disease-specific mortality in patients with grade 3 FL (FL3). Four hundred and twenty-one patients with FL who were treated with various anthracycline-based chemotherapy regimens were included in this retrospective study. Patients with FL3 and a diffuse component of >50% had the worst outcome, with a hazard ratio of dying of 2.2 (95% CI 1.4-3.4) compared with patients with FL1 or FL2, and a ratio of 1.6 (95% CI 1.02-2.5) compared with FL3 with a diffuse component of < or =50% by multivariate analysis (P = 0.0026). Patients with FL3a had an outcome similar to those with FL3b. In patients with FL3 and a diffuse component of < or =50%, the overall and event-free survival curves showed a plateau for patients younger than 60 years of age. However, there were no differences in the cumulative incidence of relapse/progression or lymphoma-specific/treatment-related mortality between the two age groups. Less than half of the patients with FL3 and a diffuse component of < or =50% treated with anthracycline-based combination chemotherapy will relapse and r...Continue Reading

References

Jul 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianF F Cabanillas
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W BezwodaJ A Moreno-Nogueira
Jul 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N L BartlettS J Horning
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L Longo
Feb 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R AndersonJ O Armitage
Oct 23, 1997·Hematology/oncology Clinics of North America·T P MillerR I Fisher
Feb 24, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RodriguezF Cabanillas
Aug 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E MaartenseE M Noordijk
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat

❮ Previous
Next ❯

Citations

Aug 12, 2006·Current Oncology Reports·Andrew J Davies
Jan 4, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Joseph M Connors
Jul 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·A A McCormickR Levy
Nov 11, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J ShustikL H Sehn
Sep 1, 2007·Current Opinion in Oncology·Philip J Bierman
Mar 21, 2007·Journal of Clinical Pathology·Sonam Prakash, Steven H Swerdlow
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan W FriedbergBrian K Link
Oct 13, 2012·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Fredrick B Hagemeister
Sep 2, 2011·Haematologica·Nancy Lee Harris, Philip Kluin
Oct 15, 2008·Leukemia & Lymphoma·Christian BuskeWyndham Wilson
Jan 19, 2008·Leukemia & Lymphoma·James O Armitage
Jun 9, 2009·Leukemia & Lymphoma·Sharathkumar BhagavathiDennis D Weisenburger
Aug 17, 2011·Seminars in Diagnostic Pathology·Wolfram Klapper
Oct 29, 2008·Hematology/oncology Clinics of North America·Anna Johnston, Gilles Salles
Oct 16, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Matthew Lunning, James O Armitage
Apr 5, 2014·British Journal of Haematology·Joslin M BowenDennis D Weisenburger
Jul 30, 2014·Clinical Lymphoma, Myeloma & Leukemia·Gayatri Vaidyanathan, Myron S Czuczman
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Laurie H SehnGinna G Laport
Jun 2, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Amrita KrishnanStephen J Forman
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas RelanderRandy D Gascoyne
Jul 9, 2013·The Cochrane Database of Systematic Reviews·Gilad ItchakiMical Paul
Sep 12, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ambrogio FassinaRocco Cappellesso
Jun 1, 2009·Expert Review of Hematology·Peter McLaughlin
Nov 25, 2006·Hematology·Laurie H Sehn
Oct 17, 2017·Annals of Hematology·Marc Sorigue, Juan-Manuel Sancho
Jun 27, 2020·Hematology/oncology Clinics of North America·Ciara L Freeman, Laurie H Sehn
Dec 18, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M J OvermanL E Fayad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.